regn910-3
Showing 1 - 3 of 3
Neovascular Age-Related Macular Degeneration Trial in United States (REGN910-3, Intravitreal Aflibercept Injection (IAI))
Completed
- Neovascular Age-Related Macular Degeneration
- REGN910-3
- Intravitreal Aflibercept Injection (IAI)
-
Mobile, Alabama
- +86 more
May 1, 2019
Diabetic Macular Edema Trial in United States (REGN910-3, Intravitreal Aflibercept Injection (IAI))
Completed
- Diabetic Macular Edema
- REGN910-3
- Intravitreal Aflibercept Injection (IAI)
-
Mesa, Arizona
- +50 more
Oct 1, 2018
Neovascular Age-Related Macular Degeneration, Diabetic Macular Edema Trial in United States (REGN910-3, REGN910, Intravitreal
Completed
- Neovascular Age-Related Macular Degeneration
- Diabetic Macular Edema
- REGN910-3
- +2 more
-
Beverly Hills, California
- +4 more
Jan 11, 2016